Study Diagnoses Health of Rx Ad Spending

july 1, 2004  08:25 am
A study released this week by Consumer Health Sciences is the latest in a line promoting the value of pharmaceutical advertising, which has exploded in the 10 years since the federal government loosened rules about drug advertising. But it remains controversial, as critics have wondered whether the ads themselves generate demand instead of solving existing medical conditions.

The consumers who respond to DTC advertising score lower in physical and mental health and spend more money on prescriptions than the general population. Specifically, they're 29 percent more likely to have concurrent diseases, spend 21 percent more time going to the doctor's, and buy 29 percent more prescription drugs than the general population.